Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Carola Steiger"'
Autor:
Bernd Schlereth, Mathias Locher, Pauline Wimberger, Benjamin Guller, Thomas Urbig, Sonja Offner, Ralf Lutterbuese, Robert Hofmeister, Andreas Wolf, Iduna Fichtner, Antonio J. da Silva, Rainer Kimmig, Tobias Raum, Peter Kufer, Klaus Brischwein, Carola Steiger, Petra Kleindienst, Patrick A. Baeuerle
Publikováno v:
Molecular Immunology. 43:1129-1143
We have developed a novel single-chain Ep-CAM-/CD3-bispecific single-chain antibody construct designated MT110. MT110 redirected unstimulated human peripheral T cells to induce the specific lysis of every Ep-CAM-expressing tumor cell line tested. MT1
Autor:
Francis V. Chisari, Carola Steiger, Robert Thimme, David W. Oldach, Kyong-Mi Chang, Stuart C. Ray
Publikováno v:
The Journal of Experimental Medicine
The virological and immunological features of hepatitis C virus (HCV) infection were studied weekly for 6 months after accidental needlestick exposure in five health care workers, four of whom developed acute hepatitis that progressed to chronicity w
Autor:
A J da Silva, Klaus Brischwein, Nadja Prang, Carola Steiger, Patrick A. Baeuerle, A Wöppel, P Göster, J Müller, Susanne Preithner, M Peters
Publikováno v:
British Journal of Cancer
MT201 is a fully human monoclonal IgG1 antibody with moderate affinity for epithelial cell adhesion molecule (Ep-CAM) being clinically developed for the treatment of carcinomas. Like many other clinically validated IgG1 monoclonal antibodies, MT201 p
Autor:
Carola Steiger, Keith A. Reimann, Stefan Wieland, Francis V. Chisari, Robert H. Purcell, John Ghrayeb, Robert Thimme
Although the CD4+- and CD8+-T-cell responses to the hepatitis B virus (HBV) are thought to be crucial for the control of HBV infection, the relative contribution of each T-cell subset as an effector of viral clearance is not known. To examine this qu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b454eb5eb7a9495b034206108336dab8
https://europepmc.org/articles/PMC140637/
https://europepmc.org/articles/PMC140637/
Autor:
Jens Bukh, Stefan Wieland, Robert Thimme, Francis V. Chisari, Carola Steiger, Robert H. Purcell, Sugantha Govindarajan, Janell Pemberton, Hans Christian Spangenberg
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 99(24)
To define the early events that determine the outcome of acute hepatitis C virus (HCV) infection, we compared the course of viremia with the peripheral and intrahepatic T cell response and intrahepatic cytokine profile in six acutely infected chimpan
Autor:
Doris Rau, Patrick A. Baeuerle, Carola Steiger, Peter Kufer, Patrick Hoffmann, Evelyn Ebert, Petra Meier, Tobias Raum, Susanne Mangold, Roman Kischel, Majk Kvesic, Susanne Hausmann, Susanne Strasser, Claudia Bluemel, Ronny Cierpka
Publikováno v:
Cancer Research. 70:2434-2434
BiTE antibodies are designed to transiently connect target cells with T cells of patients for induction of potent redirected lysis of cancer cells. Clinical proof-of-concept has been obtained with CD19/CD3-bispecific BiTE antibody blinatumomab (MT103